mRNA-based seasonal influenza vaccines: an overview of immunogenicity, efficacy, and safety

Alexander Domnich, Andrea Orsi · 2026

Read mRNA-based seasonal influenza vaccines: an overview of immunogenicity, efficacy, and safety by Alexander Domnich, Andrea Orsi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13617365.txt.

Description

Alexander Domnich and Andrea Orsi shared an overview in twenty twenty-six. It is about messenger RNA shots for seasonal flu. Most flu shots are still grown in eggs. That way is slow, and the match can be poor. The review pulls trial data on the top mRNA candidates. Some stand alone. Some pair flu cover with COVID-19 cover in one shot.

Moderna's standalone shot is now approved in the United States. Its flu-COVID mix won approval in Europe not long ago. Once the designs were tuned, the shots gave strong antibody and T cell responses. They worked best against influenza A. In older adults, one shot beat standard shots by about twenty-seven percent in relative efficacy. A rival shot worked in younger adults. It failed to match standard shots in the oldest group.

Catalog record

CREATORAlexander Domnich, Andrea Orsi
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE89 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13617365

Browse the full library · About the Tower of Babel